A

ALLOZYNE

3 employees

Allozyne develops technologies that improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Autoimmunity & Inflammation
Antibody-Drug Conjugates
Therapeutics
Oncology
Site-Specific Bioconjugation

Date founded

2005

Funding rounds raised

Total raised

$30M

from 6 investors over 6 rounds

A

ALLOZYNE raised $30M on October 26, 2007

Investors: ARCH Venture Partners, OVP Venture Partners and MPM Capital

A

ALLOZYNE raised $3.5M on December 6, 2005

Investors: OVP Venture Partners, MPM Capital and ARCH Venture Partners

FAQ